The #AMAJournalofEthics sponsors an Art of Medicine contest for works in visual media that explore ethical dimensions of health or health care. The winning artist must be a resident or fellow, and will receive a prize of up to $5,000: spr.ly/6010kwkDw

To mark the 5th anniversary of the #AMAJorunalofEthics ' Art of Medicine internship program with the School of the Art Institute of Chicago, we invite art submissions to the June 2025 issue. School of the Art Institute of Chicago spr.ly/6013kwkhX

When global medical supply chains fail, what should physicians do? In this article, Maura McGinnity explores this conundrum: spr.ly/6019kwFfz

Nisha Quasba joins #EthicsTalk to discuss her article, coauthored with Elliot Vice: “What Should Prescribers and Policy Makers Know About US Drug Importation?”: spr.ly/6015kwFN5

International medicine importation raise ethics and safety questions that should be considered when weighing affordability against risk of harm, argue Nisha Quasba, MPH and Elliot Vice : spr.ly/6019kwFFd

Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains, write Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader: spr.ly/6019kwFvB U.S. Pharmacopeia AMA Ed Hub™

The WHO has a list of essential medicines. This article by Courtney Perlino, MPP, Hilary Daniel, and Amy B. Cadwallader asks about medicines that might not get to patients who need them on time: spr.ly/6016kwFqj U.S. Pharmacopeia AMA Ed Hub™

Many international experts exchange ideas about vulnerabilities of medical supply chains and how failure to make them more resilient is an ethics problem. Read this letter from the editor by Amy B. Cadwallader. spr.ly/6017kwFoX U.S. Pharmacopeia

Each spring, the #AMAJournalofEthics poses a question in ethics and professionalism as the topic for the contest. The author of the best essay receives a prize of up to $5,000: spr.ly/6014kwk6Y

We invite manuscripts for this May 2025 issue of the #AMAJorunalofEthics that consider how clinicians and organizations should respond to lucrative incentives to sell to private equity entities: spr.ly/6014kwkcQ

Hilary Daniel joins #EthicsTalk to discuss her article, coauthored with Courtney Perlino and Amy B. Cadwallader: “Which Drugs Should Be on the Essential Medicines List?”: spr.ly/6016kwFYe

In this interview, Amy B. Cadwallader joins #EthicsTalk to discuss how critical medicine supply chains are identified and secured: spr.ly/6010kwFcG

Dr Christy Rentmeester joins #EthicsTalk to discuss her article, “You Are What You Eat . . . and What You Take Orally, Intravenously, or Topically”: spr.ly/6017kwFg7

Should we interrogate our bioproduct supply chains as we have begun interrogating our food supply chains? Christy A. Rentmeester, PhD explores this question in her article: spr.ly/6016kwFDG

Dr Hanni Stoklosa and Mike Schiller joins #EthicsTalk to discuss their article, coauthored with Dr Mollie Gordon, et al, “How Should Health Care Organizations Limit Roles of Human Trafficking in Their Labor and Supply Chains?”: spr.ly/6015kwFBW

Little attention has been given to roles played by human trafficking in health care organizations’ supply chains of key equipment, such as hand sanitizers and gloves. Read the full article by Mollie Gordon, MD, et al: spr.ly/6015kw0h3

In instances of conflict, there have even been reports of health care and aid workers teaming up with smugglers to provide needed medical supplies during shortages. Read more from Carly Ching, PhD and Muhammad H. Zaman, PhD: spr.ly/6012kw07E

Recent increases in the frequency of shortages require more rationing by clinicians. Read the full discussion by Erin R. Fox, PharmD, MHA and Matthew K. Wynia, MD, MPH: spr.ly/6017kw0fD

Check out these #AMAJournalofEthics articles and podcasts examining pressing health care topics confronting patients and the public: spr.ly/6010kwX7y